Some of the content on this website requires JavaScript to be enabled in your web browser to function as intended. While the website is still usable without JavaScript, it should be enabled to enjoy the full interactive experience.

Skip to Main Navigation. Each navigation link will open a list of sub navigation links.

Skip to Main Content

UW Technologies Available for Licensing|Wyoming Research Products Center

Nanoparticles for Cytoplasmic Drug Delivery to Cancer Cells

Description of Technology:

This invention consists of layered nanoparticles for delivering high levels of anticancer drugs to cancer cells. The nanoparticles include an outer shell, an inner core and an intermediate layer. The core is comprised of the anticancer drug or drugs and polymer chains that are soluble at the lysosomal pH of the cancer cell. The intermediate layer is comprised of polymer chains that are insoluble at the pH of the cancer interstitium. The outer shell is comprised of water-soluble polymer chains to shield the nanoparticle from recognition by the reticuloendothelial systems so as to provide the nanoparticle with a long circulation time in the bloodstream of a subject.


Applications for this technology include providing a device for the delivery of anticancer drugs preferentially to cancer cells, as well as to provide nanoparticles for the rapid release of anticancer drugs to cancer cells.

Features and Benefits:

A benefit of this technology is that cancer cells will be specifically targeted, while not targeting healthy tissue. This technology will also provide a rapid release of anticancer drugs to the cancer cells, improving treatment for cancer patients.

For More Information Please Contact:

Davona Douglass, J.D.
(307) 766-2509

Share This Page:

Tech ID



Patent Status

Filed - US Patent Application PCT Application WO 2007/001356 A2

Footer Navigation

University of Wyoming Medallion
1000 E. University Ave. Laramie, WY 82071 // UW Operators (307) 766-1121 // Contact Us // Download Adobe Reader // Accessibility Accessibility information icon